News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Rami Komrokji: Our paper addressing pattern of lower risk myelodysplastic syndrome progression
Photo from Rami Komrokji/Twitter
Feb 9, 2024, 05:19

Rami Komrokji: Our paper addressing pattern of lower risk myelodysplastic syndrome progression

Quoting Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Centre and Research Institute, on X/Twitter:

”Early View / Hematologica our paper addressing pattern of LRMDS progression. Majority don’t progress and molecular signatures can identify direct AML progression.”

Source: Rami Komrokji/X

AML progression cancer Cancer research Haematologica LRMDS progression molecular signatures OncoDaily Oncology Rami Komrokji
Special Coverage
Blog
Sep 11, 2024, 11:11
Join the upcoming CPOEM Foundation webinar on Head and Neck Cancer
Blog
Sep 11, 2024, 10:55
The EORTC Projects and Services department is looking for two PMs
Blog
Sep 11, 2024, 10:52
Thejus Jayakrishnan: My first faculty retreat at Dana-Farber Cancer Institute
Blog
Sep 11, 2024, 10:37
How germline testing can guide screening and treatment options - Sylvester Comprehensive Cancer Center
Blog
Sep 11, 2024, 10:25
Deborah McNamara: An exciting day at RCSI and more to come with conferrings next week
Blog
Sep 11, 2024, 10:21
Suzanne Lentzsch: Celebrating Krina Patel in her new role as Myeloma Section Chief at MD Anderson Cancer Center
Blog
Sep 11, 2024, 10:06
Registration open for the Inaugural Kyle-Barlogie Memorial Sloan Kettering-Mayo Clinic Plasma Cell Disorders Symposium
Blog
Sep 11, 2024, 10:00
Herbert Loong: Discussions on lung cancer screening policies in Asia-Pacific region at APCLC
Insight
Sep 11, 2024, 09:23
Myeloma Paper of the Day, September 11th, suggested by Robert Orlowski
Insight
Sep 11, 2024, 09:16
Naveen Pemmaraju: Pivekimab sunirine in relapsed or refractory acute myeloid leukaemia
Blog
Sep 11, 2024, 09:14
Highlights from WCLC24 in Mandarin led by Chunxia Su - IASLC
Blog
Sep 11, 2024, 09:12
David Dellamonica: Thrilled to be part of ESMO2024